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FIRST ANNOUNCEMENT 
International Symposium on Inherited Epidermolysis Bullosa will be held April 25 - 26, 1994, 
sponsored by the Department of Dermatology and The Office of Continuing Medical Educa-
tion, University of North Carolina School of Medicine and The National Epidermolysis Bul-
losa Registry (NEBR) . 
An intensive two day meeting is planned which will include lectures and panel discussions by 
leading authorities in the field. A poster session will also be held. Clinical topics include 
subclassification of EB phenotypes, demographic and epidemiologic findings from the NEBR 
and other cohorts, application of biostatistical modeling techniques as predictors of diagnosis 
and prognosis, carcinogenesis and EB, critical re-evaluation of laboratory diagnostic criteria, 
and multifaceted approaches to therapy. Basic research topics will include qualitative and 
morphometric ultrastructural changes within skin in selected EB phenotypes, altered antige-
nicity as a marker of disease, the role of enzymes in the pathogenesis ofEB, and a mini-sympo-
sium on the molecular biology of EB. 
For more detailed information and registration and abstract forms, contact Jo-David Fine, 
M.D., M.P.H., Department of Dermatology, The University of North Carolina at Chapel 
Hill, 137 NCMH, CB# 7600, Chapel Hill, NC 27514, (919) 966-3321, FAX (919) 966-3921. 
